1McGarry JD. Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes[ J]. Diabetes, 2002;51 ( 1 ) :7-18.
2Rossetti L, Giaccari A, DeFronzo RA. Glucose toxicity [ J]. Diabetes Care, 1990;13:610.
3Sun Y, Liu S, Ferguson S, et al. Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice[ J]. J Biol Chem,2002 ;277:23301-7.
4Kitt FP, Gerald IS. Etilogy of insulin resistance[ J]. Am J Med, 2006; 119(5A) : s10-6.
5Yu C, Chen Y, Cline GW, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 ( IRS-1 ) -associated phosphatidylinositol 3-kinase activity in muscle[ J]. J Biol Chem, 2002 ;277: 50230-6.
6Barbara M, Janja M, Andrej J,et al. Molecular mechanism of insulin resistance and associated diseases[ J]. Clin Chim Acta, 2006 ;375:20-35.
7Randlc PJ, Hales CN, Garland PB, et al. The glucose fatty acid cyde. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus[ J]. Lancet, 1963 ;1:785-9.
8Yoshikawa H, Tajiri Y, Sako Y, et al. Effects of free fatty acids on β- cell functions: a possible involvement of peroxisome proliferators-activated receptors α or pancreatic/duodenal homeobox [ J ] . Metabolism, 2001; 50: 613-8.
9Grundy SM, Hansen B, Smith SC, et al, Clinical Management of Metabolic Syndrome. Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on scientific issues related to management [ J ]. Circulation, 2004 ; 109:551-6.
10Ferrannini E, Haffner SM, Mitchell BD, et al. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome [J]. Diabetologia, 1991 ;34,416-22.
2[5]Gurwitz JH,Field Ts,Glynn RJ,et al.Risk factors for non-insulin dependent diabetes mellitus requiring treatment in the elderly[J].J AM Geriatr Soc,1994,42:1235-1240
3[6]Boyko EJ,Fujimoto WY,leonetti DL,et al.Visceral adiposity and risk of type 2 diabetes:a prospective study among Japanese Americans[J].Diabetes Care,2000,23(4):465-471
4[7]Abadie J M,Malcom G T,Porter J R,et al.Canassociations between free fatty acid levels and metabolic parameters determine insulin resistance development in obese Zucker rats[J].Life Sci,2001,69:2675-2683
5[8]Ana TMGS,Guenther B,Maria ERS,et al.Overnigt lowering of free fatty acid with Acipimox improves insulin resistance and glucose toler ance in obese diabetic and nondiabetic subjects[J].Diabetes,1999,48:1836-1841
6[9]Prelevic G M.Insulin resistance in polycystic ovary syndrome[J].Curr Opin Obstet Gynecol,1997,9:193-201
7[10]Guenther B.Role of fatty acids in the pathogenesis of insulin resistance and NIDDM[J].Diabetes,1997,46:3-10
8[11]Boden G.Fatty acids and insulin resistance[J].Diabetes Care,1996,19(4):394-39
9[12]Steinberg GR,Dyck DJ,Calles-Escandon J,et al.Chronic leptin administration decreases fatty acid uptake and fatty acid transporters in rat skeletal Muscle[J].J Biol Chem,2002,277:8854-8860
10[13]Francesco,Roberto,Mafalde.Obesity and body fat distribution induce endothelial dysfunction by oxidative stress[J].Diabetes,2001,50:159-165
